Abstracts: Diabetic retinopathy is the leading cause of blindness in the working-age 18 population in many countries. Despite the available treatments, some patients present 19 late in the course of the disease when treatment is more difficult. Hence, it is crucial 20 that the new targets are found and utilized in clinical therapy of diabetic retinopathy.
Introduction
response plays an important role in the pathogenesis of DR [7] . Moreover, the high 48 expression levels of pro-inflammatory cytokines are examined in retinas from animals 49 with diabetes [5] . Therefore, the inhibition of inflammatory signaling can become a 50 treatment for DR therapy. 51 The inflammasome is a multiprotein scaffolding complex which includes a 52 member of NOD-like receptor family, pyrin domain containing family member 53 (NLRP), procaspase 1 and apoptosis associated speck-like protein containing CARD 54 [9] . To data, NLRP3 inflammasome can leads to secretion of pro-inflammatory 55 cytokine IL-1β through recognizing danger signals and apoptosis associated 56 speck-like protein to activate caspase-1 [9] . Related reports illustrate that NLRP3 57 activation play a crucial role in metabolic disease, such as type 2 diabetes [10] . 58 Moreover, clinical samples in various stages of diabetic patients show that expression 59 of the NLRP3 and related inflammatory protein are increased in vitreous sample, 60 which have the largest response in patients with proliferative DR [11] . Thus, it 61 appears that the NLRP3 inflammasome may be involved in retinal disease.
62
Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated 63 protein kinase kinase kinase (MAP3K) family, is an important stress responsive 64 protein kinase which play crucial role in the initiation of many diseases including 65 neurodegenerative, cardiovascular, inflammatory, autoimmunity, and metabolic 66 disorders [12, 13] . The MAPK member, p38, is a serine/threonine protein kinase, 67 which responds to several cellular processes and external stress signaling, such as cell 68 differentiation, cell proliferation, inflammation regulation and cells death [14, 15] .
69
ASK1 is the most studied family member and is an upstream kinase of the JNK and 70 p38 pathways [16, 17] . Previous studies shows that ASK1 is activated in response to a 71 variety of stress-related stimuli via distinct mechanisms and activates MKK4 and 72 MKK3, which in turn activate JNK and p38 [18] . Related studies reports that ASK1/2 73 signaling complex contributes to pyroptotic cell death by regulating the NLRP3 74 inflammasome [19] . Although ASK1/p38 play a substantial role in inflammatory, and 75 it contribution in DR pathogenesis has not been described.
76
In this study, we constructed the DR animal model and the high model in 77 HRMEC cell to investigate the relationship between ASK1/p38 and NLRP3 in DR. 78 We found that ASK1/p38 could mediate NLRP3 inflammasome signaling pathway 79 contributed to aberrant retinal angiogenesis in DR. It suggested that ASK1/p38 could 80 become a new target in DR treatment.
81

Material and methods
82
Cells culture and stimulation 83 The Primary Human Retinal Microvascular Endothelial cell (HRMECs) was 84 purchased from Cell systems (Kirkland, WA, USA), and routinely cultured in M199 85 medium (Millipore, Temecula, CA) supplemented with100 units of penicillin and 100 86 μg of streptomycin per milliliter of medium. All cells (passages 5 -12) were cultured 87 in grade plastic-ware and maintained in an atmosphere of 5% CO 2 at 37°C.
88
For high glucose cell models, HRMECs were cultured in conditioned medium 89 with 5 mM (serving as the normal glucose (NG) group) or 30 mM (HG group) 90 D-glucose (Sigma, Darmstadt, Germany) and incubated at 37°C with 5% CO 2; then,
91
HG group was treated with or without 1 μM NLRP3 inhibitor CY-09 92 (MedChemExpress, New Jersey, USA), 1 μM ASK1 inhibitor New Jersey, USA) showed that the mRNA expression levels of IL-6, TNF-α and IL-1β were enhanced in 178 retina of DR groups compared with control group (Figure 1A) . Then, the formation of 179 microvascular in retina was analyzed, and the expression of vascular marker CD31 180 was increased in DR group by confocal detection (Figure 1B) . Meanwhile, the VEGF 181 secretion levels in DR group was increased compared with control group (Figure 1C ).
182
All of these data suggested that DR could cause inflammatory response and HRMECs was up-regulated, and inhibited after treated inhibitor ( Figure 2E ). In HG
200
HRMECs groups, IL-6, TNF-α and IL-1β mRNA expression levels were enhanced 201 comparing with control, and inhibited by NLRP3 inhibitor ( Figure 2F ). The result of 202 VEGF secretion levels in cells was similar with DR animal model ( Figure 2G ). Taken 203 together, this data illustrated that NLRP3-mediated tissue inflammatory response 204 promoted microvascular proliferation in retina.
205
The tube formation of retinal microvascular endothelial was inhibited through 206 blocking NLRP3 207 Above data showed that NLRP3 was related with inflammatory response and 208 promoted vascular marker CD31 and VEGF expression. Hence, we analyzed the tube 209 formation of retinal microvascular endothelial in retina. Figure 3A showed that the 210 lumen formation was obviously enhanced in HG HRMECs and was inhibited by 211 blocking NLRP3. Then, the tube meshes, nodes and tube length was counted, and the 212 results exhibited that HRMECs in high glucose could form more meshes and nudes 213 than control; meanwhile, the tube total length in HG group was higher than control 214 group ( Figure 3B-C) . However, after blocking NLRP3, the tube meshes, nudes and 215 tube length was reduced comparing with HG group (Figure 3B-C) . These data 216 suggested that the tube formation of retinal microvascular endothelial was inhibited 217 through blocking NLRP3.
218
The expression level of inflammatory some NLRP3 was up-regulated through 219 activating ASK1/p38 signal axis 220 More and more data show that NLRP3-induced inflammatory play an important 221 part in DR [9] . However, the potential mechanism of NLRP3 participating in 222 inflammatory in DR still unknown. So, we utilized the DR model and high glucose
223
HRMECs model to investigate. The results showed that the protein expression levels Figure 5A and 5C showed that high glucose could promote the tube 239 formation, and the formation was inhibited by ASK1 and p38 inhibitor. Meanwhile, 240 the tube meshes, nodes and tube length was counted. The result showed that 241 HRMECs in high glucose could form more meshes and nudes than control; 242 meanwhile, the tube total length in HG group was higher than control group ( Figure   243 5B and D). However, after blocking ASK1 and p38, the tube meshes, nudes and tube 244 length was reduced comparing with HG group (Figure 5B and D) . These data 245 suggested that ASK1/p38 signal axis participated in tube formation of retinal 246 microvascular endothelial.
247
The angiogenesis was inhibited through blocking ASK1 and p38 248 Next, we investigated whether ASK1 and p38 mediated the angiogenesis. The 249 results showed that angiogenesis related marker IB4 was obviously increased in HD 250 model ( Figure 6A and B) ; However, IB4 expression was inhibited through blocking 251 ASK1 and p38 ( Figure 6A and B) .This data suggested that ASK1 and p38 participated 252 in angiogenesis in DR. In this study, we had uncovered the NLRP3 played an important part in aberrant 261 retinal angiogenesis in diabetic retinopathy. We firstly found that ASK1/p38-mediated 262 NLRP3 inflammasome signaling pathway contributed to aberrant retinal angiogenesis 263 in diabetic retinopathy. The inflammatory related cytokines (IL-6, TNF-α, IL-1β) 264 mRNA expression levels were up-regulated in DR ( Figure 1A) ; meanwhile, vascular 265 related marker CD31 and cytokine VEGF were also increased in DR ( Figure 1B-C) .
266
After blocking NLRP3, ASK1 or p38, the expression levels of inflammatory cytokine 267 was down-regulated and vascular related marked IB4 expression was decreased.
268
It is the crucial reason that heperglycemia lead to a series of inflammatory (Figure 2A) . Then, the DR group was treated with NLRP3 inhibitor; after inhibitor 280 treatment, the inflammation cytokines IL-6, TNF-α and IL-1β mRNA expression 281 levels were decreased comparing with DR group without treated with inhibitor 282 ( Figure 2B ). Meanwhile, CD31 expression level was reduced in inhibitor treatment 283 group ( Figure 2C) . Moreover, the VEGF secretion level was reduced after 284 administrated with NLRP3 inhibitor ( Figure 2D ). Moreover, the NLRP3 protein 285 expression level in HG HRMECs group was up-regulated, and inhibited after treated 286 inhibitor ( Figure 2E ). In HG HRMECs groups, IL-6, TNF-α and IL-1β mRNA 287 expression levels were enhanced comparing with control, and inhibited by NLRP3 288 inhibitor ( Figure 2F ). The result of VEGF secretion levels in cells was similar with 289 DR animal model ( Figure 2G ).
290
ASK1 is an apoptosis-related protein, which is activated in response to a variety 291 of stress-related stimuli via distinct mechanisms and activates MKK4 and MKK3, 292 which in turn activate JNK and p38 [29] . Many reports illustrate that ASK1 can 293 contribute to the development and progression of inflammatory response [30, 31] . For 294 example, the bacterial infection-engaged inhibition of ASK1 is responsible for 295 regulating Erk1/2-and p38-MAPKs activation, but not JNK-MAPK signaling [31, 32] .
296
This previous studies suggest that ASK1 and p38 have close relationship in could form more meshes and nudes than control; meanwhile, the tube total length in 466 HG group was higher than control group. However, after blocking NLRP3, the tube 467 meshes, nudes and tube length was reduced comparing with HG group. In addition, 
